Literature DB >> 17056101

Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history.

Analía Sánchez-Luceros1, Susana S Meschengieser, Karina Turdó, Adriana Arizó, Adriana I Woods, Patricia Casais, Alicia N Blanco, Ana C Kempfer, María A Lazzari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17056101     DOI： 10.1016/j.thromres.2006.09.004

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease.

Authors:  Nathan T Connell; Veronica H Flood; Romina Brignardello-Petersen; Rezan Abdul-Kadir; Alice Arapshian; Susie Couper; Jean M Grow; Peter Kouides; Michael Laffan; Michelle Lavin; Frank W G Leebeek; Sarah H O'Brien; Margareth C Ozelo; Alberto Tosetto; Angela C Weyand; Paula D James; Mohamad A Kalot; Nedaa Husainat; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

Review 2.  Principles of care for the diagnosis and treatment of von Willebrand disease.

Authors:  Giancarlo Castaman; Anne Goodeve; Jeroen Eikenboom
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

3.  Desmopressin acetate (DDAVP) for preventing and treating acute bleeds during pregnancy in women with congenital bleeding disorders.

Authors:  Laxminarayan Karanth; Ankur Barua; Sachchithanantham Kanagasabai; N Sreekumaran Nair
Journal:  Cochrane Database Syst Rev       Date:  2019-02-13

4.  Desmopressin acetate use in von Willebrand's disease: a survey on current practices in Brazil.

Authors:  Maria Sueli da Silva Namen Lopes; Suely Meireles Rezende
Journal:  Hematol Transfus Cell Ther       Date:  2020-01-30

5.  Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease.

Authors:  Giancarlo Castaman
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-07-16       Impact factor: 2.576
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.